Intelligence Platform

Patents

Browse 763 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 8999290

Papillomavirus pseudoviruses for detection and therapy of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8986701

Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of pro

The Board of Regents of the University of Oklahoma · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8968234

Method of using vasoconstrictive agents during energy-based tissue therapy

Covidien LP · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8962593

GLA monotherapy for use in cancer treatment

IMMUNE DESIGN CORP. · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8962797

Halogenated compounds for photodynamic therapy

NANOQUANTUM SCIENCES, INC. · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8957047

GLA monotherapy for use in cancer treatment

IMMUNE DESIGN CORP. · Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945108

Method of using vasoconstrictive agents during energy-based tissue therapy

Covidien LP · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8911722

Modulation of yeast-based immunotherapy products and responses

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8883500

Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherap

Northwestern University · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8859520

Methods for therapy of neurodegenerative disease of the brain

The Regents of the University of California · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853277

Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cel

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8852936

Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy

Laurantis Pharma Oy · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846034

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

HALOZYME, INC. · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846889

Peptide biosynthesis and pain therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8840905

Use of neurotoxin therapy for treatment of urologic and related disorders

The Regents of the University of Colorado · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8834938

Use of arsenic for cancer therapy protection

The Board of Regents of the University of Texas System · Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8835167

Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8829024

Combination steroid and glucocorticoid receptor antagonist therapy

Corcept Therapeutics Incorporated · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8815212

Nanocarriers for imaging and therapy applications

The Board of Regents of the University of Texas System · Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8815229

Granulysin in immunotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8809268

Combination therapy to combat helminth resistance

The Regents of the University of California · Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8795738

Use of arsenic for cancer therapy protection

The Board of Regents of the University of Texas System · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8784802

Ischemic tissue cell therapy

Cryopraxis Criobiologia Ltda. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8759302

Methods of treating a subject afflicted with an autoimmune disease using predictive biomar

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)